• IDEXX Laboratories Executive Chair of the Board Jonathan Jay Mazelsky sold 25,140 common shares on November 4, 2026.
• Reported sale prices ranged from $698.2625 to $711.9475 per share.
• Mazelsky also exercised non-qualified stock options for 25,140 common shares at $178.26 per share.
• His direct common stock holdings totaled 83,803 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEXX Laboratories Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000874716-26-000144), on November 05, 2026, and is solely responsible for the information contained therein.